结核分枝杆菌CFP10-ESAT6融合蛋白在大肠杆菌中的高效表达

摘要/Abstract

摘要： 目的　在大肠杆菌中高效融合表达结核分枝杆菌分泌蛋白ESAT 6和CFP 10 ,获得纯化的重组ESAT6 CFP10 (rCFP10 ESAT6 )融合蛋白抗原。方法通过聚合酶链反应 (polymerasechainreaction ,PCR)扩增CFP10 ESAT6融合基因 ;以质粒pET 2 8a为表达载体 ,构建重组质粒 ,转化大肠杆菌BL2 1(DE3) ;以异丙基硫代半乳糖苷 (IPTG)诱导表达目的蛋白 ,通过SDS PAGE电泳和蛋白免疫印迹法 (Westernblotting)鉴定rCFP10 ESAT6在大肠杆菌中的表达 ,确定rCFP10 ESAT6蛋白抗原在大肠杆菌中的表达形式 ;采用ChelatingSepharoseFastFlow蛋白纯化试剂纯化重组蛋白。West ernblotting及酶联免疫吸附试验 (ELISA)分析重组蛋白的免疫原性。结果重组质粒pET2 8a CFP10 ESAT6中目的基因测序结果与报道序列相同 ;在大肠杆菌中以可溶性形式表达 ;分子量约2 8kDa ,表达量约占菌体总蛋白的 4 6 % ,纯化后的rCFP10 ESAT6样品经SDS PAGE和激光密度扫描分析表明其纯度为 90 %左右 ,每 10 0ml培养菌可获得 16mg左右的重组蛋白 ;Western印迹结果证实重组蛋白与His·tag单克隆抗体及确诊的肺结核病患者血清发生特异免疫反应。ELISA结果分析表明 ,该重组抗原能区分肺结核患者血清及正常人血清。结论成功地表达和纯化了结核分枝杆菌CFP10-ESAT6融合蛋白。该重组蛋白具有特异的免疫原性。

关键词: 分枝杆菌,结核/抗原, CFP-10, ESAT-6, 基因表达, 免疫学

Abstract: Objective To obtain the recombinant CFP10-ESAT6 fused protein of M.tuberculosis .Methods The gene coding CFP-10 and ESAT-6 protein was amplified by polymerase chain reaction (PCR).The gene was inserted into an expression vector pET-28a to get recombinant plasmid.The recombinant plasmid was transformed into E.coli BL21(DE3).The E.coli carrying recombinant plasmid were induced by IPTG.The expressed product was indentified by SDS-PAGE and purified by metal chelation chromatography,and its immunological characteristics were analyzed by Western-blotting and ELISA technology.Results The sequence of CFP-10 and ESAT-6 in recombinant plasmid was consistented to that of Genbank report. The recombinant CFP10-ESAT6 protein was highly expressed in the form of solution in E.coli ,which was confirmed by Western-blotting analysis with monoclonal antibody against 6×His·tag and TB patient serum .ELISA test Results indicated that the purified recombinant protein could distinguish sera from tuberculosis patients and those from healthy people.Conclusion The recombinant CFP10-ESAT6 protein was expressed and purified successfully in the form of solution in E.coli and showed specific immunogenicity.

Key words: Mycobacterium tuberculosis /antigen, ESAT-6, CFP-10, Gene expression, Immunological

李娟,吴雪琼,张俊仙,李香兰,张灵霞,梁建琴,. 结核分枝杆菌CFP10-ESAT6融合蛋白在大肠杆菌中的高效表达[J]. 中国防痨杂志, 2004, 26(4): 204-208.

Li Juan,Wu Xueqiong,Zhang Junxian,et al.. Fused expression of Mycobacterium tuberculosis CFP-10 and ESAT-6 protein in Ecoli[J]. Chinese Journal of Antituberculosis, 2004, 26(4): 204-208.

参考文献

1 Mahairas G G, Sabo P J, hickey M J, et al. Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M.bovis [J]. Bacteriol, 1996,178:1274～1282.
2 Berthet F X, Rasmussen P B, Rosenkrands I, et al. A Mycobacteri-um tuberculosis operon encoding ESAT-6 and a novel low-molecu-lar-mass culture filtrate protein (CFP-10) [J]. Microbiology,1998,144:3195～3203.
3 Davin C D, Mark R A, Craig H D, et al. Molecular and immuno-logical characterization of Mycobacterium tuberculosis CFP-10, an immunodiagnostic antigen missing in Mycobacterium bovis BCG[J]. Journal of Clinical Microbiology,2000,38(9)：3285～3290.
4 Renshaw P S, Panagiotidou P, Whelan A, et al. CFP-10 complex implications for pathogenesis and virulence [J]. Biol Chem, 2002，277(24) :21598～21603.
5 van Pinxteren L A H, Ravn P, Agger EM, et al. Diagnosis of tu-berculosis based on the two specific antigens ESAT-6 and CFP10 [J]. Clinical and Diagnostic Laboratory Immunology, 2000, 7：155-160.
6 Bates J H The tuberculin skin test and preventative treatment for tuberculosis [J]. Tuberculosis, 1996,865～872.
7 Sandra M A rend, Peter Andersen, Krista E. van Meijgaarden，et al. Detection of active tuberculosis infection by T-ceU response to early-secreted antigenic target 6-kDa protein and culture filtrate protein 10 [ J ]. The Journal of Infectious Diseases, 2000, 181 ：1850～1854.
8 Sorensen A L, Nagai S, Hou'en G, et al. Purification and charac-terization of a low molecular mass T-cell antigen secreted by M yco-bacterium tuberculosis [J]. Infect Immune 1995,63：1710～ 1717.
9 张灵霞，吴雪琼,史迎昌，等.结核分枝杆菌重组ESAT6蛋白抗原诱发豚鼠迟发性超敏反应的研究[J].中华结核和呼吸杂志，2001,24(6)：383-384.
10 蒋玉凤,钟森，史小玲，等.结核分枝杆菌ESAT-6真核表达质粒的构建及蛋白表达的鉴定[J].中国人兽共患病杂志,2003,19(5):63～69.
11 陈全,骆旭山,蒋英,等.结核分枝杆菌lhp基因原核表达载体的构建和表达[J].细胞与分子免疫学杂志，2003,19(4):332～334.
12 陈全,骆旭山，蒋英,等.结核分枝杆菌CFP10-ESAT6融合蛋白的制备[J].中华微生物学和免疫学杂志,2002,22(6):648.
13 Haslqvk, Andersen A B, Nagai S, el al. Guinea pig celluar immune responses to protein secreted by mycobacterium tuberculosis [J].Infect Immune, 1995,63:804～810.

[1]	张凯, 陶立峰, 韦芬, 都伟欣, 仇晶晶, 陈伟, 陈保文, 朱银猛, 程兴, 苏城, 钟再新, 卢锦标, 蒲江. 重组结核杆菌融合蛋白(EC)的免疫特性和临床前安全性研究[J]. 中国防痨杂志, 2020, 42(8): 807-813.
[2]	张蓝月,耿艺漫,贾红彦,肖婧,李自慧,潘丽萍,孙义成,张宗德. 耻垢分枝杆菌新型毒素-抗毒素系统MSMEG_3435-3436基因功能的初步研究[J]. 中国防痨杂志, 2020, 42(2): 133-142.
[3]	马进宝, 马婷婷, 任斐, 杨翰, 谭淦纹. 涂阳肺结核患者γ-干扰素释放试验假阴性的影响因素分析[J]. 中国防痨杂志, 2020, 42(12): 1299-1304.
[4]	石倩, 陈志. 风湿性疾病并发肺结核患者的三种免疫学指标检测结果分析[J]. 中国防痨杂志, 2020, 42(10): 1087-1091.
[5]	丁光贵,贺星,梁娟,刘亚亚,欧敏,陆坚,张国良. miR-20a-5p调控结核分枝杆菌诱导巨噬细胞凋亡相关基因表达的研究[J]. 中国防痨杂志, 2019, 41(7): 747-753.
[6]	赵爱华,王国治,徐苗. 我国结核病免疫学预防、治疗与诊断用制品发展进程与展望[J]. 中国防痨杂志, 2019, 41(11): 1149-1154.
[7]	丁晓娟,刘毅,孙涛,周小丹,李传友,方海红. Ra1362调控环二鸟苷酸影响结核分枝杆菌H37Ra的生物膜发育和休眠[J]. 中国防痨杂志, 2018, 40(6): 616-621.
[8]	凌彦博，梁艳，王小美，等. 中药复方牛贝消核提取物治疗结核病相关靶标的研究[J]. 中国防痨杂志, 2016, 38(1): 17-22.
[9]	张荧，朱慧，梁倩，赵立平，黄海荣，黄娟，孙照刚. 色氨酸-犬尿氨酸代谢中间产物对结核病患者T细胞免疫的影响[J]. 中国防痨杂志, 2015, 37(4): 333-338.
[10]	詹森林，张国良，钟红剑，金晓菲，林巧，张明霞，陈心春，周伯平. 不同毒性Mtb菌株对Ⅰ型干扰素基因的诱导作用及其在结核病患者外周血中的表达[J]. 中国防痨杂志, 2015, 37(1): 35-39.
[11]	张俊仙，梁艳，吴雪琼. 我国结核病基础研究的回顾与展望[J]. 中国防痨杂志, 2014, 36(9): 755-763.
[12]	张国良，詹森林，钟红剑，林巧，汪文斐，金晓菲，张明霞，陈心春. 结核分枝杆菌感染对Ⅰ型干扰素受体基因表达的影响及其在结核病患者外周血表达的意义[J]. 中国防痨杂志, 2014, 36(6): 482-486.
[13]	史祥，唐亮，粟波. 结核性胸膜炎患者胸腔积液T淋巴细胞及白细胞介素-2的变化[J]. 中国防痨杂志, 2014, 36(12): 1067-1070.
[14]	张影陆坚侯志平张明霞陈心春张兴树邱振纲. 肺结核患者疗程中外周血辅助性和调节性T细胞的动态研究[J]. 中国防痨杂志, 2013, 35(6): 427-432.
[15]	孙蕾郑锦辉王毳费思平赵卓. 衔接分子胱天蛋白酶募集域蛋白9与抗结核免疫的相关性[J]. 中国防痨杂志, 2013, 35(3): 204-206.